SyntheticMR Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 3/6
SyntheticMR's earnings have been declining at an average annual rate of -6.4%, while the Healthcare Services industry saw earnings growing at 16.1% annually. Revenues have been growing at an average rate of 13.2% per year. SyntheticMR's return on equity is 8.6%, and it has net margins of 10.6%.
Anahtar bilgiler
-6.4%
Kazanç büyüme oranı
-7.2%
EPS büyüme oranı
| Healthcare Services Sektör Büyümesi | -11.7% |
| Gelir büyüme oranı | 13.2% |
| Özkaynak getirisi | 8.6% |
| Net Marj | 10.6% |
| Sonraki Kazanç Güncellemesi | 21 May 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
Should You Think About Buying SyntheticMR AB (publ) (NGM:SYNT) Now?
Dec 20
What Does SyntheticMR AB (publ)'s (NGM:SYNT) Share Price Indicate?
Sep 21Some Investors May Be Worried About SyntheticMR's (NGM:SYNT) Returns On Capital
Mar 18There Are Reasons To Feel Uneasy About SyntheticMR's (NGM:SYNT) Returns On Capital
Nov 29What Does SyntheticMR AB (publ)'s (NGM:SYNT) Share Price Indicate?
Aug 06Why SyntheticMR AB (publ) (NGM:SYNT) Could Be Worth Watching
Feb 23A Look At The Intrinsic Value Of SyntheticMR AB (publ) (NGM:SYNT)
Jan 27Should You Think About Buying SyntheticMR AB (publ) (NGM:SYNT) Now?
Nov 10Read This Before Selling SyntheticMR AB (publ) (NGM:SYNT) Shares
Mar 09What Percentage Of SyntheticMR AB (publ) (NGM:SYNT) Shares Do Insiders Own?
Feb 11
SyntheticMR AB (publ) (NGM:SYNT) Insiders Increased Their Holdings
Dec 03Gelir ve Gider Dağılımı
SyntheticMR nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 31 Dec 23 | 94 | 10 | 43 | 0 |
| 30 Sep 23 | 85 | 6 | 42 | 0 |
| 30 Jun 23 | 83 | 6 | 40 | 0 |
| 31 Mar 23 | 80 | 7 | 37 | 0 |
| 31 Dec 22 | 74 | 6 | 35 | 0 |
| 30 Sep 22 | 71 | 8 | 33 | 0 |
| 30 Jun 22 | 65 | 7 | 31 | 0 |
| 31 Mar 22 | 58 | 2 | 30 | 0 |
| 31 Dec 21 | 63 | 8 | 30 | 0 |
| 30 Sep 21 | 60 | 8 | 29 | 0 |
| 30 Jun 21 | 57 | 5 | 29 | 0 |
| 31 Mar 21 | 55 | 3 | 29 | 0 |
| 31 Dec 20 | 52 | 1 | 27 | 0 |
| 30 Sep 20 | 47 | -6 | 29 | 0 |
| 30 Jun 20 | 48 | -3 | 27 | 0 |
| 31 Mar 20 | 51 | 2 | 26 | 0 |
| 31 Dec 19 | 48 | 4 | 24 | 0 |
| 30 Sep 19 | 53 | 12 | 23 | 0 |
| 30 Jun 19 | 52 | 13 | 22 | 0 |
| 31 Mar 19 | 50 | 14 | 20 | 0 |
| 31 Dec 18 | 51 | 15 | 19 | 0 |
| 30 Sep 18 | 49 | 14 | 18 | 0 |
| 30 Jun 18 | 45 | 12 | 17 | 0 |
| 31 Mar 18 | 39 | 8 | 16 | 0 |
| 31 Dec 17 | 38 | 8 | 16 | 0 |
| 30 Sep 17 | 34 | 8 | 15 | 0 |
| 30 Jun 17 | 30 | 7 | 13 | 0 |
| 31 Mar 17 | 28 | 6 | 12 | 0 |
| 31 Dec 16 | 22 | 2 | 12 | 0 |
| 30 Sep 16 | 15 | 1 | 9 | 0 |
| 30 Jun 16 | 14 | 4 | 8 | 0 |
| 31 Mar 16 | 11 | 1 | 9 | 0 |
| 31 Dec 15 | 9 | 0 | 9 | 0 |
| 30 Sep 15 | 7 | -4 | 10 | 0 |
| 30 Jun 15 | 5 | -9 | 11 | 0 |
| 31 Mar 15 | 5 | -8 | 10 | 0 |
| 31 Dec 14 | 4 | -7 | 9 | 0 |
| 30 Sep 14 | 5 | -6 | 9 | 0 |
| 30 Jun 14 | 5 | -5 | 8 | 0 |
| 31 Mar 14 | 5 | -5 | 7 | 0 |
| 31 Dec 13 | 4 | -5 | 7 | 0 |
| 30 Sep 13 | 4 | -4 | 6 | 0 |
Kaliteli Kazançlar: SYNT has a high level of non-cash earnings.
Büyüyen Kar Marjı: SYNT's current net profit margins (10.6%) are higher than last year (8%).
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: SYNT's earnings have declined by 6.4% per year over the past 5 years.
Büyüme Hızlandırma: SYNT's earnings growth over the past year (70.3%) exceeds its 5-year average (-6.4% per year).
Kazançlar vs. Sektör: SYNT earnings growth over the past year (70.3%) exceeded the Healthcare Services industry 70.3%.
Özkaynak Getirisi
Yüksek ROE: SYNT's Return on Equity (8.6%) is considered low.